Percutaneous tracheostomy after mechanical ventricular assist device implantation

Igor D. Gregoric, Matthew T. Harting, Roman Kosir, Vijaykumar Surendrakant Patel, Jus Ksela, Gregory N. Messner, Saverio La Francesca, O. H. Frazier

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Several studies have shown that percutaneous dilational tracheostomy (PDT) is safe and cost-effective for patients recovering from surgery that requires a median sternotomy. We report our experience with PDT in patients receiving mechanical cardiac assistance. Methods: We reviewed the medical records of all patients who underwent ventricular assist device implantation at our institution between July 2000 and July 2003, and who subsequently required long-term ventilatory support during the same hospital admission. Data obtained from the records included demographic and biometric information, primary diagnosis, early (≤30days) and late (>30days) complications, date and cause of death, type of anti-coagulation used at the time of tracheostomy, and various coagulation measures. Results: Thirty-one consecutive patients (29 men, 2 women; mean age, 56 years) had PDT after ventricular assist device implantation. Four minor complications occurred among 3 of the patients (10%), including 3 early complications (2 peristomal oozing and 1 peristomal cellulitis) and 1 late complication (recurrent peristomal cellulitis), none of which affected long-term outcome. No major adverse events, long-term complications, or deaths resulted from the PDT procedure. Conclusions: PDT is feasible for patients with mechanical support devices who require long-term ventilatory support. Although some of these patients are coagulopathic, our results indicate that PDT is safe and effective in this challenging patient population.

Original languageEnglish (US)
Pages (from-to)1513-1516
Number of pages4
JournalJournal of Heart and Lung Transplantation
Volume24
Issue number10
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Fingerprint

Heart-Assist Devices
Tracheostomy
Cellulitis
Sternotomy
Medical Records
Cause of Death
Demography
Costs and Cost Analysis
Equipment and Supplies

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Cite this

Gregoric, I. D., Harting, M. T., Kosir, R., Patel, V. S., Ksela, J., Messner, G. N., ... Frazier, O. H. (2005). Percutaneous tracheostomy after mechanical ventricular assist device implantation. Journal of Heart and Lung Transplantation, 24(10), 1513-1516. https://doi.org/10.1016/j.healun.2004.12.109

Percutaneous tracheostomy after mechanical ventricular assist device implantation. / Gregoric, Igor D.; Harting, Matthew T.; Kosir, Roman; Patel, Vijaykumar Surendrakant; Ksela, Jus; Messner, Gregory N.; La Francesca, Saverio; Frazier, O. H.

In: Journal of Heart and Lung Transplantation, Vol. 24, No. 10, 01.10.2005, p. 1513-1516.

Research output: Contribution to journalArticle

Gregoric, ID, Harting, MT, Kosir, R, Patel, VS, Ksela, J, Messner, GN, La Francesca, S & Frazier, OH 2005, 'Percutaneous tracheostomy after mechanical ventricular assist device implantation', Journal of Heart and Lung Transplantation, vol. 24, no. 10, pp. 1513-1516. https://doi.org/10.1016/j.healun.2004.12.109
Gregoric, Igor D. ; Harting, Matthew T. ; Kosir, Roman ; Patel, Vijaykumar Surendrakant ; Ksela, Jus ; Messner, Gregory N. ; La Francesca, Saverio ; Frazier, O. H. / Percutaneous tracheostomy after mechanical ventricular assist device implantation. In: Journal of Heart and Lung Transplantation. 2005 ; Vol. 24, No. 10. pp. 1513-1516.
@article{12e6e6881c8c4a60b610a076506348bf,
title = "Percutaneous tracheostomy after mechanical ventricular assist device implantation",
abstract = "Background: Several studies have shown that percutaneous dilational tracheostomy (PDT) is safe and cost-effective for patients recovering from surgery that requires a median sternotomy. We report our experience with PDT in patients receiving mechanical cardiac assistance. Methods: We reviewed the medical records of all patients who underwent ventricular assist device implantation at our institution between July 2000 and July 2003, and who subsequently required long-term ventilatory support during the same hospital admission. Data obtained from the records included demographic and biometric information, primary diagnosis, early (≤30days) and late (>30days) complications, date and cause of death, type of anti-coagulation used at the time of tracheostomy, and various coagulation measures. Results: Thirty-one consecutive patients (29 men, 2 women; mean age, 56 years) had PDT after ventricular assist device implantation. Four minor complications occurred among 3 of the patients (10{\%}), including 3 early complications (2 peristomal oozing and 1 peristomal cellulitis) and 1 late complication (recurrent peristomal cellulitis), none of which affected long-term outcome. No major adverse events, long-term complications, or deaths resulted from the PDT procedure. Conclusions: PDT is feasible for patients with mechanical support devices who require long-term ventilatory support. Although some of these patients are coagulopathic, our results indicate that PDT is safe and effective in this challenging patient population.",
author = "Gregoric, {Igor D.} and Harting, {Matthew T.} and Roman Kosir and Patel, {Vijaykumar Surendrakant} and Jus Ksela and Messner, {Gregory N.} and {La Francesca}, Saverio and Frazier, {O. H.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1016/j.healun.2004.12.109",
language = "English (US)",
volume = "24",
pages = "1513--1516",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Percutaneous tracheostomy after mechanical ventricular assist device implantation

AU - Gregoric, Igor D.

AU - Harting, Matthew T.

AU - Kosir, Roman

AU - Patel, Vijaykumar Surendrakant

AU - Ksela, Jus

AU - Messner, Gregory N.

AU - La Francesca, Saverio

AU - Frazier, O. H.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Background: Several studies have shown that percutaneous dilational tracheostomy (PDT) is safe and cost-effective for patients recovering from surgery that requires a median sternotomy. We report our experience with PDT in patients receiving mechanical cardiac assistance. Methods: We reviewed the medical records of all patients who underwent ventricular assist device implantation at our institution between July 2000 and July 2003, and who subsequently required long-term ventilatory support during the same hospital admission. Data obtained from the records included demographic and biometric information, primary diagnosis, early (≤30days) and late (>30days) complications, date and cause of death, type of anti-coagulation used at the time of tracheostomy, and various coagulation measures. Results: Thirty-one consecutive patients (29 men, 2 women; mean age, 56 years) had PDT after ventricular assist device implantation. Four minor complications occurred among 3 of the patients (10%), including 3 early complications (2 peristomal oozing and 1 peristomal cellulitis) and 1 late complication (recurrent peristomal cellulitis), none of which affected long-term outcome. No major adverse events, long-term complications, or deaths resulted from the PDT procedure. Conclusions: PDT is feasible for patients with mechanical support devices who require long-term ventilatory support. Although some of these patients are coagulopathic, our results indicate that PDT is safe and effective in this challenging patient population.

AB - Background: Several studies have shown that percutaneous dilational tracheostomy (PDT) is safe and cost-effective for patients recovering from surgery that requires a median sternotomy. We report our experience with PDT in patients receiving mechanical cardiac assistance. Methods: We reviewed the medical records of all patients who underwent ventricular assist device implantation at our institution between July 2000 and July 2003, and who subsequently required long-term ventilatory support during the same hospital admission. Data obtained from the records included demographic and biometric information, primary diagnosis, early (≤30days) and late (>30days) complications, date and cause of death, type of anti-coagulation used at the time of tracheostomy, and various coagulation measures. Results: Thirty-one consecutive patients (29 men, 2 women; mean age, 56 years) had PDT after ventricular assist device implantation. Four minor complications occurred among 3 of the patients (10%), including 3 early complications (2 peristomal oozing and 1 peristomal cellulitis) and 1 late complication (recurrent peristomal cellulitis), none of which affected long-term outcome. No major adverse events, long-term complications, or deaths resulted from the PDT procedure. Conclusions: PDT is feasible for patients with mechanical support devices who require long-term ventilatory support. Although some of these patients are coagulopathic, our results indicate that PDT is safe and effective in this challenging patient population.

UR - http://www.scopus.com/inward/record.url?scp=25844435915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25844435915&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2004.12.109

DO - 10.1016/j.healun.2004.12.109

M3 - Article

VL - 24

SP - 1513

EP - 1516

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 10

ER -